Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ceprotin 500unit inj vials
0211000X0BBAAAA
|
Ceprotin | Protein C concentrate | Cardiovascular System | No data available |
|
Cerivastatin 100microgram tablets
0212000C0AAAAAA
|
Cerivastatin | Cerivastatin | Cardiovascular System | No data available |
|
Cerivastatin 200microgram tablets
0212000C0AAABAB
|
Cerivastatin | Cerivastatin | Cardiovascular System | No data available |
|
Cerivastatin 300microgram tablets
0212000C0AAACAC
|
Cerivastatin | Cerivastatin | Cardiovascular System | No data available |
|
Cerivastatin 400microgram tablets
0212000C0AAADAD
|
Cerivastatin | Cerivastatin | Cardiovascular System | No data available |
|
Cerivastatin 800microgram tablets
0212000C0AAAEAE
|
Cerivastatin | Cerivastatin | Cardiovascular System | No data available |
|
Certoparin sodium 3,000units/0.3ml inj pre-filled syringes
0208010B0AAAAAA
|
Certoparin sodium | Certoparin sodium sodium | Cardiovascular System | No data available |
|
Cevenfacta 1mg (45,000units) inj vials
0211000Z0BCAAAL
|
Cevenfacta | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Cevenfacta 2mg (90,000units) inj vials
0211000Z0BCABAM
|
Cevenfacta | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Cevenfacta 5mg (225,000units) inj vials
0211000Z0BCACAN
|
Cevenfacta | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Chlorothiazide 100mg/5ml oral suspension
0202010D0AABKBK
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 10mg/5ml oral liquid
0202010D0AABEBE
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 12.5mg/5ml oral liquid
0202010D0AABWBW
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 120mg/5ml oral liquid
0202010D0AACPCP
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 125mg/5ml oral suspension
0202010D0AABBBB
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 140mg/5ml oral liquid
0202010D0AACJCJ
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 143mg/5ml oral liquid
0202010D0AACUCU
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 155mg/5ml oral liquid
0202010D0AABPBP
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 15mg/5ml oral liquid
0202010D0AACRCR
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 160mg/5ml oral liquid
0202010D0AACSCS
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 187.5mg/5ml oral liquid
0202010D0AABUBU
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 200mg/5ml oral solution
0202010D0AABIBI
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 20mg/5ml oral suspension
0202010D0AABQBQ
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 225mg/5ml oral liquid
0202010D0AACDCD
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
|
Chlorothiazide 240mg/5ml oral liquid
0202010D0AACICI
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.